Motif Bio Share Discussion Threads

[waterloo01] 29/12/2017 07:56

Tipped in sharemagazine

Drug developer ImmuPharma (IMM:AIM) is expecting Phase III results in the first quarter of 2018 for lupus treatment Lupuzor. Analysts speculate the drug could hit multi-billion dollar annual sales if the tests are successful and the drug gets approved by the regulators.

MotifBio (MTFB:AIM) believes its drug Iclaprim for serious skin infections could be approved by the US Food and Drug Administration and a product licence confirmed by the end of 2018, having recently completed the two necessary Phase III trials.

[chadders] 28/12/2017 18:59

MTFB IMM SPE DKL PHC

[longshanks] 28/12/2017 16:48

MTFB, IMM, HUR, SCE, ODX

[tilly99] 28/12/2017 16:41

Yes mine WaterlooAlong with WDC blu and ntknSell note here 7bucks ..idiots

[flavio_monteiro] 28/12/2017 16:28

Rizler.....IMM, MTFB & VAL

[rizler] 28/12/2017 16:07

Long shanks, what else you got in your top 5?Open to everyone else too...I've got BLU, imm, vrs, mtfb and AVO

[escapetohome] 28/12/2017 16:01

Wow , better close those shorts and very fast indeed.

Thats my kind advice.

[master rsi] 28/12/2017 15:47

she has gone to 38p bid now, and not many left at 38.50p 0ffer 6K

[master rsi] 28/12/2017 15:23

On the UP also on the US

Market summary > MOTIF BIO PLC/S ADR

NASDAQ: MTFB - Dec 28, 9:56 AM EST
10.40 USDPrice increase 0.35 (3.48%)

[escapetohome] 28/12/2017 12:33

Close the shorts guys- dont be stupid.

[longshanks] 28/12/2017 12:32

Seems like someone has a downer on MTFB still, with IG showing 5% of open positions are short!!The new extended run space for AMP into mid 2018 has yet to really sink in it seems, and offers a great opportunity to get in here cheap. That won't last.One of my top 5 for 2018 too.

[tilly99] 28/12/2017 11:44

My tip of the year along with blu

[t-trader] 28/12/2017 11:20

Nice move this morning, hopefully this is where the re-rate starts. 2018 should be a great year for MOTIF.

[longshanks] 22/12/2017 10:48

Thanks, I can trade US shares too with iWeb but whilst dealing costs are very low, the range is limited. They don't do warrants at all. I will take a look at AJ Bell.

[timbo003] 22/12/2017 10:29

I think most online brokers will deal in US listed shares/securities longshanks, but they may require you to fill in an W8-BEN (which takes less than a minute).

I have purchased US shares with my AJ Bell account and my TD Waterhouse account.

If all else fails, I would use a private client broker such as Cornhill, or Turner Pope Investments (where I have accounts).

I currently own a few warrants (which came as part of one of the November 2016 placing in which I participated through Cornhill). I am currently holding these in certificated form (through choice).

[longshanks] 22/12/2017 09:17

I need a better broker. Do you use an online broker Tim with access to NASDAQ warrants and if so - which one?

[timbo003] 22/12/2017 08:35

This strikes me as fairly significant news and removes what was probably be the biggest factor in holding the share price down.

Those US listed warrants may start to look interesting

[metis20] 22/12/2017 08:31

From the recent additional results RNS

“Iclaprim has been designated as a Qualified Infectious Disease Product (QIDP) by the U.S. Food and Drug Administration (FDA). This designation includes Priority Review upon acceptance of a New Drug Application (NDA), and, if approved, it is anticipated that iclaprim will be eligible to receive 10 years of market exclusivity in the U.S. from the date of approval. The FDA has also granted Fast Track designation for iclaprim. Motif Bio plans to submit an NDA by the end of the first quarter of 2018.”



and from -



“A Priority Review designation means FDA’s goal is to take action on an application within 6 months”

[small crow] 22/12/2017 08:25

Yes, and stop the sharks getting their dubloons.

[1savvyinvestor] 22/12/2017 08:24

Definitely lampoon. We could then harpoon all the shorters

[longshanks] 22/12/2017 08:09

Harpoon or lampoon?

[pjj71] 22/12/2017 07:53

lets just hope some of the sharks get lampooned by the news.. no doubt they will try to depress the share price as much as possible!!!

[longshanks] 22/12/2017 07:49

The lender benefits from 10% of any appreciation in MTFB too - so there is an incentive on their part to sell shares in blocks to willing buyers rather than just dump the shares onto the market.All the ducks are lining up: the NDA will have been submitted by June 2018 and within 6 months of that there will be commercial sales of Iclaprim.Clearly the terms and details of this loan have been thought through carefully to benefit all sides equally and dissuade the sharks from thinking an attack can work.

[tilly99] 22/12/2017 07:40

This has been a big overhang Expect 40p to be hot today We have fallen from 52p cos of worries over Amp holding Onwards and upwards?

[pjj71] 22/12/2017 07:24

FDA approval will be granted by then and probably the first ex US farmout... this should be 100p by now...